Impact of cyadox on human colonic microflora in chemostat models

Regulatory Toxicology and Pharmacology

Volumn 67, Issue 3, 2013, Pages 335-343

  Hao, Haihong ^a   Guo, Weige ^a   Iqbal, Zahid ^a   Cheng, Guyue ^a   Wang, Xu ^a   Dai, Menghong ^a   Huang, Lingli ^a   Wang, Yulian ^a   Peng, Dapeng ^a   Liu, Zhenli ^a   Yuan, Zonghui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Chemostat; Cyadox; Human colonic microflora; Microbiological safety

Indexed keywords

CIADOX; SHORT CHAIN FATTY ACID;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; CHEMOSTAT; COLON FLORA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SAFETY; ENTEROCOCCUS; ESCHERICHIA COLI; FECES MICROFLORA; FEMALE; HUMAN; MALE; MICROBIAL COMMUNITY; NONHUMAN; OQXAB GENE; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ESCHERICHIA COLI; SALMONELLA TYPHIMURIUM;

CHEMOSTAT; CYADOX; HUMAN COLONIC MICROFLORA; MICROBIOLOGICAL SAFETY;

ANTI-INFECTIVE AGENTS; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM; COLON; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; ESCHERICHIA COLI; FECES; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; NO-OBSERVED-ADVERSE-EFFECT LEVEL; QUINOXALINES; SALMONELLA TYPHIMURIUM; VETERINARY DRUGS;

EID: 84887624468     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2013.08.011     Document Type: Article

References (38)

1. Aarestrup F.M., Bager F., Jensen N.E., Madsen M., Meyling A., Wegener H.C. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. Apmis 1998, 106:606-622.
2. Allison C., McFarlan C., MacFarlane G.T. Studies on mixed populations of human intestinal bacteria grown in single-stage and multistage continuous culture systems. Appl. Environ. Microbiol. 1989, 55:672-678.
3. Carman R.J., Woodburn M.A. Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora. Regul. Toxicol. Pharmacol. 2001, 33:276-284.
4. Carman R.J., Simon M.A., Fernandez H., Miller M.A., Bartholomew M.J. Ciprofloxacin at low levels disrupts colonization resistance of human fecal microflora growing in chemostats. Regul. Toxicol. Pharmacol. 2004, 40:319-326.
5. Carman R.J., Simon M.A., Petzold H.E., Wimmer R.F., Batra M.R., Fernandez A.H., Miller M.A., Bartholomew M. Antibiotics in the human food chain: establishing no effect levels of tetracycline, neomycin, and erythromycin using a chemostat model of the human colonic microflora. Regul. Toxicol. Pharmacol. 2005, 43:168-180.
6. Cihak R., Srb V. Cytogenetic effects of quinoxaline-1,4-dioxide-type growth-promoting agents. I. Micronucleus test in rats. Mutat. Res. 1983, 116:129-135.
7. CLSI, 2009, Methods for antimicrobial susceptibility testing of anaerobic bacteria-Seventh Edition. Approved standard M11-A6. Clinical and Laboratory Standards Institute.
8. CLSI, 2010, Performance standards for antimicrobial susceptibility testing; Nineteenth Informational Supplement. Approved standard M100S20E. Clinical and Laboratory Standards Institute.
9. Corpet D.E. The effect of bambermycin, carbadox, chlortetracycline and olaquindox on antibiotic resistance in intestinal coliforms: a new animal model. Ann. Microbiol. 1984, 135A:329-339.
10. Corpet D.E. Microbial ecology of the intestine. In vitro, in vivo and mathematical models. Rev. Sci. Tech. Off. Int. Epiz 1989, 8:391-403.
11. Ding M.X., Wang Y.L., Zhu H.L., Yuan Z.H. Effects of cyadox and olaquindox on intestinal mucosal immunity and on fecal shedding of Escherichia coli in piglets. J. Anim. Sci. 2006, 84:2367-2373.
12. Dvorak M. Increasing the effectiveness of feed mixtures for the early weaning of piglets with the addition of fats or growth stimulators. Vet. Med. 1984, 29:151-162.
13. Fang G., He Q., Zhou S., Wang D., Zhang Y., Yuan Z. Subchronic oral toxicity study with cyadox in Wistar rats. Food Chem. Toxicol. 2006, 44:36-41.
14. FDA, 2005, Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to estabilish a microbiological ADI FDA Final guidance #159.
15. Guo W., Hao H., Dai M., Wang Y., Huang L., Peng D., Wang X., Wang H., Yao M., Sun Y., Liu Z., Yuan Z. Development of quinoxaline 1,4-dioxides resistance in Escherichia coli and molecular change under resistance selection. PloS One 2012, 7:e43322.
16. Hansen L.H., Johannesen E., Burmolle M., Sorensen A.H., Sorensen S.J. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob. Agents Chemother. 2004, 48:3332-3337.
17. Hansen L.H., Sorensen S.J., Jorgensen H.S., Jensen L.B. The prevalence of the OqxAB multidrug efflux pump amongst olaquindox-resistant Escherichia coli in pigs. Microb. Drug Resist. 2005, 11:378-382.
18. He Q., Fang G., Wang Y., Wei Z., Wang D., Zhou S., Fan S., Yuan Z. Experimental evaluation of cyadox phototoxicity to Balb/c mouse skin. Photodermatol. Photoimmunol. Photomed. 2006, 22:100-104.
19. Hedges A.J., Linton A.H. Olaquindox resistance in the coliform flora of pigs and their environment: an ecological study. J. Appl. Bacteriol. 1988, 64:429-443.
20. Jeong S.H., Song Y.K., Cho J.H. Risk assessment of ciprofloxacin, flavomycin, olaquindox and colistin sulfate based on microbiological impact on human gut biota. Regul. Toxicol. Pharmacol. 2009, 53:209-216.
21. Kaji I., Karaki S., Kuwahara A. Chemosense for luminal environment in the large intestine. Yakugaku Zasshi 2011, 131:1691-1698.
22. Linton A.H., Hedges A.J., Bennett P.M. Monitoring for the development of antimicrobial resistance during the use of olaquindox as a feed additive on commercial pig farms. J. Appl. Bacteriol. 1988, 64:311-327.
23. Liu B.T., Wang X.M., Liao X.P., Sun J., Zhu H.Q., Chen X.Y., Liu Y.H. Plasmid-mediated quinolone resistance determinants oqxAB and aac(6')-Ib-cr and extended-spectrum beta-lactamase gene blaCTX-M-24 co-located on the same plasmid in one Escherichia coli strain from China. J. Antimicrob. Chemother. 2011, 66:1638-1639.
24. Macfarlane S., Macfarlane G.T. Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 2003, 62:67-72.
25. Newton D.F., Macfarlane S., Macfarlane G.T. Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms. Antimicrob. Agents Chemother. 2013, 57:2016-2025.
26. Nisbet D.J., Tellez G.I., Lowry V.K., Anderson R.C., Garcia G., Nava G., Kogut M.H., Corrier D.E., Stanker L.H. Effect of a commercial competitive exclusion culture (Preempt) on mortality and horizontal transmission of Salmonella gallinarum in broiler chickens. Avian Dis. 1998, 42:651-656.
27. Nunoshiba T., Nishioka H. Genotoxicity of quinoxaline 1,4-dioxide derivatives in Escherichia coli and Salmonella typhimurium. Mutat. Res. 1989, 217:203-209.
28. Ohmae K., Yonezawa S., Terakado N. R plasmid with carbadox resistance from Escherichia coli of porcine origin. Antimicrob. Agents Chemother. 1981, 19:86-90.
29. Que J.U., Hentges D.J. Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice. Infect. Immun. 1985, 48:169-174.
30. Sorensen A.H., Hansen L.H., Johannesen E., Sorensen S.J. Conjugative plasmid conferring resistance to olaquindox. Antimicrob. Agents Chemother. 2003, 47:798-799.
31. Sun Y., Dai M., Hao H., Wang Y., Huang L., Almofti Y.A., Liu Z., Yuan Z. The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium. PloS One 2011, 6:e23471.
32. Tobe T., Nakanishi N., Sugimoto N. Activation of motility by sensing short-chain fatty acids via two steps in a flagellar gene regulatory cascade in enterohemorrhagic Escherichia coli. Infect. Immun. 2011, 79:1016-1024.
33. Wagner R.D., Holland M., Cerniglia C.E. An in vitro assay to evaluate competitive exclusion products for poultry. J. Food Prot. 2002, 65:746-751.
34. Wagner R.D., Johnson S.J., Cerniglia C.E. In vitro model of colonization resistance by the enteric microbiota: effects of antimicrobial agents used in food-producing animals. Antimicrob. Agents Chemother. 2008, 52:1230-1237.
35. Wang X., Fang G.J., Wang Y.L., Ihsan A., Huang L.L., Zhou W., Liu Z.L., Yuan Z.H. Two generation reproduction and teratogenicity studies of feeding cyadox in Wistar rats. Food Chem. Toxicol. 2011, 49:1068-1079.
36. Wang X., He Q.H., Wang Y.L., Ihsan A., Huang L.L., Zhou W., Su S.J., Liu Z.L., Yuan Z.H. A chronic toxicity study of cyadox in Wistar rats. Regul. Toxicol. Pharmacol. 2011, 59:324-333.
37. Xu N., Huang L., Liu Z., Pan Y., Wang X., Tao Y., Chen D., Wang Y., Peng D., Yuan Z. Metabolism of cyadox by the intestinal mucosa microsomes and gut flora of swine, and identification of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2011, 25:2333-2344.
38. Zhao J., Chen Z., Chen S., Deng Y., Liu Y., Tian W., Huang X., Wu C., Sun Y., Sun Y., Zeng Z., Liu J.H. Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment. Antimicrob. Agents Chemother. 2010, 54:4219-4224.